Anti-HER2 antibody therapy using gene-transduced adipocytes for HER2-positive breast cancer.

MLA

Masuda, Takahito, et al. “Anti-HER2 Antibody Therapy Using Gene-Transduced Adipocytes for HER2-Positive Breast Cancer.” Breast Cancer Research and Treatment, vol. 180, no. 3, Apr. 2020, pp. 625–34. EBSCOhost, https://doi.org/10.1007/s10549-020-05581-x.

APA

Masuda, T., Fujimoto, H., Teranaka, R., Kuroda, M., Aoyagi, Y., Nagashima, T., Sangai, T., Takada, M., Nakagawa, A., Kubota, Y., Yokote, K., & Ohtsuka, M. (2020). Anti-HER2 antibody therapy using gene-transduced adipocytes for HER2-positive breast cancer. Breast Cancer Research and Treatment, 180(3), 625–634. https://doi.org/10.1007/s10549-020-05581-x

Chicago

Masuda, Takahito, Hiroshi Fujimoto, Ryotaro Teranaka, Masayuki Kuroda, Yasuyuki Aoyagi, Takeshi Nagashima, Takafumi Sangai, et al. 2020. “Anti-HER2 Antibody Therapy Using Gene-Transduced Adipocytes for HER2-Positive Breast Cancer.” Breast Cancer Research and Treatment 180 (3): 625–34. doi:10.1007/s10549-020-05581-x.